In the subset of GIST without any of these alterations (so called quadruple wild-type GIST), targeted sequencing in two recent studies have shown the presence of activating mutations or gene fusions involving FGFR1 [9,10]. The gene discussed is FGFR1; the disease is gastrointestinal stromal tumor.